I am trying to install MACS peak caller from deb but it is saying that I dont have python 2.6 install even though I have. What could be wrong?
-
-
I'm trying to install MACS version 1.4.2 and I have python version 2.7.4 installed in Ubuntu. The MACS website says Python version must be 2.6 or 2.7 and it fails to install for me saying "macs depends on python2.6". How can I install it and will it work with 2.7.4 or do I have to downgrade to 2.6 (or 2.7?). -
Might not be picking up your version of python.should indicate what version of python you have,Code:python -V
will indicate which binary of python is being used (in case you have multiple versions in play). Is your pythonpath env variable set correctly? Are you pointing to the correct python libraries?Code:which python
The other option is going from source. Even if you don't use the compiled binary, it'll probably spit out an error message if your install fails, and that will also be useful in troubleshooting.
It looks like MACS bundles with a setup.py, so a python setup.py install --user should install MACS locally.Last edited by ctseto; 11-14-2013, 12:15 PM.Comment
-
Thank you I think it's working now, I used "python setup.pl install --user". When I type "./macs14 -h" or "./macs14 --version" it prints out the help or version number correctly.Comment
-
Now I figured out there is a new version macs2! But I got that one installed
Comment
-
Saw that as well. I had originally posted instructions to pull the newest code from git and install it locally to --user, but you seem to have gotten that sorted out.Originally posted by biznatch View PostNow I figured out there is a new version macs2! But I got that one installedComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...Today, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment